Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинКарта сайта

Поздравляем!
Поздравляем нового Логобуржца bagira со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

A pharmaceutical study on an antihypertensive drug   Sinar Sayed,Ahmed Abdel Bary and Dina Louis

A pharmaceutical study on an antihypertensive drug

192 страниц. 2015 год.
LAP Lambert Academic Publishing
This book discusses novel techniques of solubility & dissolution enhancement of -poorly water soluble drug- Olmesartan medoxomil. Olmesartan medoxomil is a selective Angiotensin II receptor blocker drug used in the treatment of hypertension. It is a model drug of the Biopharmaceutical Classification System (BCS) class II which is characterized by poor water solubility and good permeability.It suffers from low bioavailability following oral administration using traditional dosage forms due to its poor aqueous solubility and efflux by drug resistance pumps in the gastrointestinal tract. It needs to be incorporated into a dosage form that enhances its solubility and overcomes these limitations.However, formulating olmesartan medoxomil as immediate release dosage forms, possess great challenge due to its poor aqueous solubility.
 
- Генерация страницы: 0.03 секунд -